Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: Studies in a rat model

Human Reproduction

Volumn 13, Issue 11, 1998, Pages 3009-3015

  Ujioka, Takeshi ^a,b   Matsuura, Kohei ^a   Tanaka, Nobuyuki ^a   Okamura, Hitoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b TRINITY UNIVERSITY   (United States)

Author keywords

Kinin kallikrein system; Ovarian hyperstimulation syndrome; Progesterone; Rat

Indexed keywords

CHORIONIC GONADOTROPIN; EVANS BLUE; ICATIBANT; KALLIKREIN; KININ; MIFEPRISTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; FEMALE; NEWBORN; NONHUMAN; OVARY DISEASE; PATHOPHYSIOLOGY; RAT; TISSUE LEVEL;

ANIMALIA; EQUIDAE; FALLOPIA;

EID: 0031753374     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.11.3009     Document Type: Article

References (46)

1. Abramov, Y., Schenker, J.G., Lewin, A. et al. (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum. Reprod., 11, 1381-1386.
2. Balasch, J., Jimenez, W., Arroyo, V. et al. (1991) Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fertil. Steril., 56, 1077-1083.
3. Bouhnik, J., Savoie, F., Michaud, A. et al. (1989) Effect of sex hormones on plasma T-kininogen in the rat. Life Sci., 44, 1859-1866.
4. Brännström, M. and Hellberg, P. (1989) Bradykinin potentiates LH-induced follicular rupture in the rat ovary perfused in vitro. Hum. Reprod., 4,475-481.
5. Chen, L., Chung, P., Chao, S. et al. (1992) Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochem. Biophys. Acta, 1131, 145-151.
6. Clements, J.A., Mukhtar, A., Holland, A.M. et al. (1995) Kallikrein gene family expression in the rat ovary: localization to the granulosa cell. Endocrinology, 136, 1137-1144.
7. Collins, P.D., Connolly, D.T. and Williams, T.J. (1993) Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br. J. Pharmacol., 109, 195-199.
8. Davis, R., and Whittington, R. (1995) Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs, 49, 954-983.
9. Desai, P.M., Nishiwaki, K., Stuart, R.S. et al. (1994) Humoral pulmonary vasoregulation in conscious dogs after left lung autotransplantation. J. Appl. Physiol., 76, 902-908.
10. Espey, L.L., Miller, D.H. and Margolius, H.S. (1986) Ovarian increase in kinin-generating capacity in PMSG/hCG-primed immature rat. Am. J. Physiol., 251, E362-E365.
11. Espey, L.L., Tanaka, N., Winn, V. et al. (1989) Increase in ovarian kallikrein activity during ovulation in the gonadotropin-primed immature rat. J. Reprod. Fertil., 87, 503-508.
12. Gao, X., Greenbaum, L.M., Mahesh, V.B. et al. (1992) Characterization of the kinin system in the ovary during ovulation in the rat. Biol. Reprod., 47, 945-951.
13. Gergely, R.Z., Paldi, E., Erlik, Y. et al. (1976) Treatment of ovarian hyperstimulation syndrome by antihistamine. Obstet. Gynecol., 47, 83-85.
14. Griesbacher, T., Tiran, B. and Lembeck, F. (1993) Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoel40. Br. J. Pharmacol., 108, 405-411.
15. Hill, G.E., Pohorecki, R., Alonso, A. et al. (1996) Aprotinin reduces interleukin- 8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth. Anal., 83, 696-700.
16. Hill, G.E. and Robbins R.A. (1997) Aprotinin but not tranexamic acid inhibits cytoline-induced inducible nitric oxide synthesis expression. Anesth. Anal., 84,1198-1202.
17. Hock, F.J., Wirth, K., Albus, U. et al. (1991) Hoel40 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
18. Kamiya, T., Katayama, Y, Kashiwagi, F. et al. (1993) The role of bradykinin in mediating ischemic brain edema in rats. Stroke, 24, 571-576.
19. Katori, M., Majima, M., Odoi-Adome, R. et al. (1989) Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in an anesthetized rats. Br. J. Pharmacol., 98, 1383-1391.
20. Kodama, H., Matsui, T., Fukuda, J. et al. (1996) Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil. Steril., 66, 417-424.
21. Larson, L., Olofsson, J., Hellberg, P. et al. (1991) Regulation of prostaglandin biosynthesis by luteinizing hormone and bradykinin in rat preovulatory follicles in vitro. Prostaglandins, 41, 111-121.
22. Majima, M., Katori, M., Hanazuka, M. et al. (1991) Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension, 17, 806-813.
23. Majima, M., Sunahara, N., Harada, Y. et al. (1993) Detection of the degradation products of bradykinin by enzyme immunoasays as markers for the release of kinin in vivo. Biochem. Pharmacol, 45, 559-567.
24. McClure, N., Healy, D.L., Rogers, P.A.W. et al. (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-236.
25. Moohan, J.M., Healy, D., Curcio, K. et al. (1997) Low intraovarian vascular resistance: a marker for severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 728-732.
26. Neely, A.N., Hoover, D.L., Holder, I.A. et al. (1996) Circulating levels of tumor necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns, 22, 524-530.
27. Nossaman, B.D., Feng, C.J. and Kadowitz, P.J. (1994) Analysis of responses to bradykinin and influence of HOE140 in the isolated perfused rat lung. Am. J. Physio., 266, H2452-H2461.
28. Ong, A.C., Rennie, D.P., Homburg, R. et al. (1991) The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin. Endocrinol., 34, 43-49.
29. Polishuk. W.Z. and Schenker, J.G. (1969) Ovarian overstimulation syndrome. Fertil. Steril., 20, 443-450.
30. Pride, S.M., Yuen, B.H. and Moon, YS. (1984) Clinical, endocrinologic, and intraovarian prostaglandin F responses to H-l receptor blockade in the ovarian hyperstimulation syndrome: Studies in the rabbit model. Am. J. Obstet. Gynecol., 148, 670-674.
31. Proud D, and Kaplan A. (1988) Kinin formation: mechanism and role in inflammatory disorders. Ann. Rev. Immuno., 6, 49-83.
32. Regoli, D. and Barabe, J. (1980) Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
33. Revel, A., Amit, A., Barak, V. et al. (1996) Characterization of intraperitoneal cytokines and nitrites in woman with severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 66-71.
34. Sakamoto, T., Elwood, W., Barnes, PJ. et al. (1992) Effect of Hoe140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factorinduced bronchoconstriction and airway microvascular leakage in guinea pig. Eur. J. Pharmacol., 213, 367-373.
35. Sakata, Y., Akaike, T., Suga, M. et al. (1996) Bradykinin generation triggered by pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol. Immunol., 40, 415-423.
36. Schenker, J.G. and Polishuk, W.Z. (1976) The role of prostaglandins in ovarian hyperstimulation syndrome. Eur. J. Gynecol. Reprod. Biol., 6, 47-52.
37. Schenker, J. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
38. Seino, M., Carretero, O.A., Albertini, R. et al. (1982) Kinins in regulation of uteroplacental blood flow in the pregnant rabbit. Am. J. Physiol., 242, H142-H147.
39. Smith, C. and Perks, A.M. (1983a) The kinin system and ovulation: changes in plasma kininogens, and in kinin-forming enzymes in the ovaries and blood of rats with 4-day estrous cycles. Can. J. Physiol. Pharmacol., 61, 736-742.
40. Smith, C. and Perks, A.M. (1983b) Changes in plasma kininogen levels in rats before ovulation, and after treatment with luteinizing hormone and estradiol-17β. Acta Endocrinol., 104, 123-128.
41. Tanaka, N., Espey, L.L., Stacy, S. et al. (1992) Epostane and indomethacin actions on ovarian kallikrein and plasminogen activator activities during ovulation in the gonadotropin-primed immature rat. Biol. Reprod., 46, 665-670.
42. Ujioka, T., Matsuura, K., Kawano, T. et al. (1997) Role of progesterone in capillary permeability in hyperstimulated rats. Hum. Reprod. 12, 1629-1634.
43. Wassdal, I., Hull, R., Gerskowitch, V.P. et al. (1995) Kallikrein rK10-induced kinin-independent, direct activation of NO-formation and relaxation of rat isolated aortic rings. Br. J. Pharmacol, 115, 356-360.
44. Wirth, K., Hock, F.J., Albus, U. et al. (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol., 102, 774-777.
45. Yoshimura, Y., Espey, L., Hosoi, Y. et al. (1988) The effects of bradykinin on ovulation and prostaglandin production by the perfused rabbit ovary. Endocrinology, 122, 2540-2546.
46. Yuen, B.H., McComb, P., Sy, L. et al. (1979) Plasma prolactin, human chorionic gonadotropin, estradiol, testosterone, and progesterone in the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 133, 316-320.